Cardioprotective effects of fullerenol C(60)(Oh)(24) on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm (Q46805568)

25 December 2017

title

Cardioprotective effects of fullerenol C(60)(Oh)(24) on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm (English)

1 reference

25 December 2017

author name string

R Injac

1

1 reference

25 December 2017

M Perse

2

1 reference

25 December 2017

M Boskovic

3

1 reference

25 December 2017

V Djordjevic-Milic

4

1 reference

25 December 2017

A Djordjevic

5

1 reference

25 December 2017

A Hvala

6

1 reference

25 December 2017

A Cerar

7

1 reference

25 December 2017

B Strukelj

8

1 reference

25 December 2017

publication date

1 February 2008

1 reference

25 December 2017

Technology in Cancer Research and Treatment

published in

1 reference

25 December 2017

volume

7

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

15-25

1 reference

25 December 2017

A clinicopathologic analysis of adriamycin cardiotoxicity

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Early changes in myocardial antioxidant enzymes in rats treated with adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Adriamycin-induced heart failure: mechanism and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Antioxidants and cancer therapy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Modulating activity of fullerol C60(OH)22 on doxorubicin-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Nitric oxide-scavenging activity of polyhydroxylated fullerenol, C60(OH)24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Toxicity profile of dexrazoxane (zinecardR, icrf-187, adr-529, nsc-169780), a modulator of doxorubicin cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

New synthetic flavonoids as potent protectors against doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

C-phycocyanin ameliorates doxorubicin-induced oxidative stress and apoptosis in adult rat cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Activity of d,l-alpha-tocopherol (vitamin E) against cardiotoxicity induced by doxorubicin and doxorubicin with cyclophosphamide in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Examination of the mechanism(s) involved in doxorubicin-mediated iron accumulation in ferritin: studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Protein oxidation and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Inactivation of glutathione peroxidase by superoxide radical.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

Positive correlation between decreased cellular uptake, NADPH-glutathione reductase activity and adriamycin resistance in Ehrlich ascites tumor lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460800700102

10.1177/153303460800700102

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017